Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects

Status:
Completed

Trial end date:
2018-11-25

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety, tolerability and pharmacodynamics of a single iv dose of E-WE Thrombin in healthy adult subjects.

Phase 1

Aronora, Inc.

Thrombin